But think of the flip side. If the patent is not extended, it expires in 2017. If you add up the milestone payments and royalties that the company says it can expect, then the stock is worth a lot less than $4.00.
In saying that it is assumed the income from other uses of ACR's drug delivery technology is not much compared with Axiron income.
- Forums
- ASX - By Stock
- ACR
- $5.75
ACR
acrux limited
Add to My Watchlist
5.88%
!
1.6¢

$5.75, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.548M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.6¢ | $1.303K | 79.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 187934 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 358041 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 187934 | 0.016 |
5 | 1145382 | 0.015 |
3 | 391428 | 0.014 |
3 | 389550 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 358041 | 1 |
0.018 | 790901 | 3 |
0.019 | 146993 | 2 |
0.020 | 447795 | 6 |
0.021 | 122699 | 1 |
Last trade - 14.24pm 07/08/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |